These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11801559)

  • 1. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliomas: association of histology and molecular genetic analysis of chromosomes 1p, 10q, and 19q.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Sikorska B; Papierz W; Liberski PP
    Acta Neurobiol Exp (Wars); 2007; 67(2):103-12. PubMed ID: 17691218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
    Ichimura K; Pearson DM; Kocialkowski S; Bäcklund LM; Chan R; Jones DT; Collins VP
    Neuro Oncol; 2009 Aug; 11(4):341-7. PubMed ID: 19435942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy.
    Pandith AA; Zahoor W; Manzoor U; Nisar S; Guru FR; Naikoo NA; Aein QU; Baba SM; Bhat AR; Ganai F; Shah P
    Cancer Genet; 2023 Nov; 278-279():55-61. PubMed ID: 37625215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.
    Vogazianou AP; Chan R; Bäcklund LM; Pearson DM; Liu L; Langford CF; Gregory SG; Collins VP; Ichimura K
    Neuro Oncol; 2010 Jul; 12(7):664-78. PubMed ID: 20164239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp27 (HSPB1): a possible surrogate molecular marker for loss of heterozygosity (LOH) of chromosome 1p in oligodendrogliomas but not in astrocytomas.
    Castro GN; Cayado-Gutiérrez N; Moncalero VL; Lima P; De Angelis RL; Chávez V; Cuello-Carrión FD; Ciocca DR
    Cell Stress Chaperones; 2012 Nov; 17(6):779-90. PubMed ID: 22806482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.
    Lin AL; White M; Miller-Thomas MM; Fulton RS; Tsien CI; Rich KM; Schmidt RE; Tran DD; Dahiya S
    J Neurooncol; 2016 Dec; 130(3):529-533. PubMed ID: 27704386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment.
    Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
    Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.
    Ichimura K; Vogazianou AP; Liu L; Pearson DM; Bäcklund LM; Plant K; Baird K; Langford CF; Gregory SG; Collins VP
    Oncogene; 2008 Mar; 27(14):2097-108. PubMed ID: 17934521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting nanopore sequencing for characterization and grading of IDH-mutant gliomas.
    Wongsurawat T; Jenjaroenpun P; Anekwiang P; Arigul T; Thongrattana W; Jamshidi-Parsian A; Boysen G; Suriyaphol P; Suktitipat B; Srirabheebhat P; Cheunsuchon P; Tanboon J; Nookaew I; Sathornsumetee S
    Brain Pathol; 2024 Jan; 34(1):e13203. PubMed ID: 37574201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1p/19q testing has no significance in the workup of glioblastomas.
    Clark KH; Villano JL; Nikiforova MN; Hamilton RL; Horbinski C
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):706-17. PubMed ID: 23363074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord glioneuronal tumor with neuropil-like islands with 1p/19q deletion in an adult with low-grade cerebral oligodendroglioma.
    Fraum TJ; Barak S; Pack S; Lonser RR; Fine HA; Quezado M; Iwamoto FM
    J Neurooncol; 2012 Apr; 107(2):421-6. PubMed ID: 22083647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in CIC and FUBP1 contribute to human oligodendroglioma.
    Bettegowda C; Agrawal N; Jiao Y; Sausen M; Wood LD; Hruban RH; Rodriguez FJ; Cahill DP; McLendon R; Riggins G; Velculescu VE; Oba-Shinjo SM; Marie SK; Vogelstein B; Bigner D; Yan H; Papadopoulos N; Kinzler KW
    Science; 2011 Sep; 333(6048):1453-5. PubMed ID: 21817013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas.
    Pohl U; Cairncross JG; Louis DN
    Brain Pathol; 1999 Oct; 9(4):639-43. PubMed ID: 10517502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.
    Hayashi S; Sasaki H; Kimura T; Abe T; Nakamura T; Kitamura Y; Miwa T; Kameyama K; Hirose Y; Yoshida K
    Oncotarget; 2015 Jun; 6(18):15871-81. PubMed ID: 25991674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adults.
    Fukuoka K; Mamatjan Y; Ryall S; Komosa M; Bennett J; Zapotocky M; Keith J; Myrehaug S; Hazrati LN; Aldape K; Laperriere N; Bouffet E; Tabori U; Hawkins C
    Brain Pathol; 2020 May; 30(3):515-523. PubMed ID: 31630459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing.
    Demirdizen E; Al-Ali R; Narayanan A; Sun X; Varga JP; Steffl B; Brom M; Krunic D; Schmidt C; Schmidt G; Bestvater F; Taranda J; Turcan Ş
    Neuro Oncol; 2023 Jun; 25(6):1031-1043. PubMed ID: 36215168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microdeletion event at 19q13.43 in IDH-mutant astrocytomas is strongly correlated with MYC overexpression.
    Ülgen E; Gerlevik U; Gerlevik S; Oktay Y; Sezerman OU; Turcan Ş; Ozduman K
    Acta Neuropathol Commun; 2024 Jun; 12(1):95. PubMed ID: 38877600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple gliomas.
    Ryzhova MV; Galstyan SA; Telysheva EN; Petrova EI; Kobyakov GL; Khodzhaev AI; Maryashev SA
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(6):66-75. PubMed ID: 36534626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
    On J; Natsumeda M; Takahashi H; Koyama A; Shibuma S; Shibata N; Watanabe J; Saito S; Kanemaru Y; Tsukamoto Y; Okada M; Ogura R; Eda T; Tada M; Shimizu H; Adachi JI; Mishima K; Nishikawa R; Kakita A; Oishi M
    J Neurooncol; 2024 Jan; 166(2):273-282. PubMed ID: 38227143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.